Blue Zone Wealth Advisors, LLC Amgen Inc Transaction History

Blue Zone Wealth Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 04, 2021	SELL	$221.91 - $258.6 $197,499 - $230,154	-890 Closed	0 $0
Q4 2020 Jan 22, 2021	SELL	$216.38 - $257.67 $62,317 - $74,208	-288 Reduced 24.45%	890 $205,000
Q2 2020 Jul 20, 2020	SELL	$197.81 - $242.74 $9,890 - $12,137	-50 Reduced 4.07%	1,178 $278,000
Q1 2020 Apr 29, 2020	BUY	$182.24 - $241.7 $5,831 - $7,734	32 Added 2.68%	1,228 $249,000
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $226,295 - $290,867	1,196 New	1,196 $288,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Blue Zone Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Blue Zone Wealth Advisors, LLC with notifications on news.